Chunhua Qie
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Chunhua Qie has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Bei Jiang
Yunnan Key Laboratory of Screening and Research on Anti-Pathogenic Plant Resources from Western Yunnan, Institute of Materia Medica, College of Pharmacy, Dali University, Dali 671000, China
1 shared publication Hongzhang Wu
Department of Laboratory Medicine, Tianjin Second People's Hospital, Tianjin 300192, China
1 shared publication- Jing Qian
Pharmaceutical Informatics Institute, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou 310058, China
1 shared publication Ping Ma
Department of Laboratory Medicine, Tianjin Second People's Hospital, Tianjin 300192, China
1 shared publication- Qi Wu
Key Research Laboratory for Infectious Disease Prevention for State Administration of Traditional Chinese Medicine, Tianjin Institute of Respiratory Diseases, Tianjin, China
1 shared publication Yamin Liu
Department of Laboratory Medicine, Tianjin Second People's Hospital, Tianjin 300192, China
1 shared publication
Latest Publications
- Open Access
- 18 May 2023
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 136 (13) , 1618-1620
Analysis of prevailing pertussis strains from different regions in China after the application of acellular vaccines
- 18 May 2023
- Published by Wolters Kluwer Health in Chinese Medical Journal
- Vol. 136 (13) , 1618-1620
Open AccessAnalysis of prevailing pertussis strains from different regions in China after the application of acellular vaccines
- 5 August 2019
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 77 (7)
Genetic association between mannose-binding lectin polymorphisms and viral hepatitis: a meta-analysis
Some previous genetic association studies have tried to investigate potential associations between mannose-binding lectin (MBL) polymorphisms and viral hepatitis. However, the results of those studies were not consistent. Therefore, we performed the current meta-analysis to explore associations between MBL polymorphisms and viral hepatitis in a large pooled population. A systematic literature research of PubMed, Web of Science, Embase and CNKI was performed to identify eligible studies for pooled analyses. We used Review Manager version 5.3.3 to conduct statistical analyses. In total, 27 studies were included for analysis (4840 cases and 5729 controls). The pooled analyses showed that MBL promoter (-211C/G, dominant model: P = 0.0002, I2 = 40%; over-dominant model: P = 0.0001, I2 = 22%) and exon 1 (codon 52, 54 and 57, dominant model: P = 0.04, I2 = 49%; allele model: P = 0.01, I2 = 48%) polymorphisms were both significantly associated with viral hepatitis in the overall population. Further subgroup analyses revealed similarly significant findings for MBL promoter polymorphism in HBV and HCV, but no positive results were detected in subgroup analyses for MBL exon 1 polymorphism. These results suggested that MBL promoter and exon 1 polymorphisms could be used to identify individuals at higher susceptibility to HBV and HCV.
- 5 August 2019
- Published by Oxford University Press (OUP) in Pathogens and Disease
- Vol. 77 (7)
Genetic association between mannose-binding lectin polymorphisms and viral hepatitis: a meta-analysis
Some previous genetic association studies have tried to investigate potential associations between mannose-binding lectin (MBL) polymorphisms and viral hepatitis. However, the results of those studies were not consistent. Therefore, we performed the current meta-analysis to explore associations between MBL polymorphisms and viral hepatitis in a large pooled population. A systematic literature research of PubMed, Web of Science, Embase and CNKI was performed to identify eligible studies for pooled analyses. We used Review Manager version 5.3.3 to conduct statistical analyses. In total, 27 studies were included for analysis (4840 cases and 5729 controls). The pooled analyses showed that MBL promoter (-211C/G, dominant model: P = 0.0002, I2 = 40%; over-dominant model: P = 0.0001, I2 = 22%) and exon 1 (codon 52, 54 and 57, dominant model: P = 0.04, I2 = 49%; allele model: P = 0.01, I2 = 48%) polymorphisms were both significantly associated with viral hepatitis in the overall population. Further subgroup analyses revealed similarly significant findings for MBL promoter polymorphism in HBV and HCV, but no positive results were detected in subgroup analyses for MBL exon 1 polymorphism. These results suggested that MBL promoter and exon 1 polymorphisms could be used to identify individuals at higher susceptibility to HBV and HCV.